Mosafe 2.5Mg contains following Salts:-
Mosapride - Drug Information
Typical usage: :Disorders associated with decreased GI motility.
Probable Side Effects: :Diarrhea, abdominal pain, dizziness, constipation, headache, sleeplessness, nausea and vomiting.
Drug Interaction: Tell your doctor of all prescription and nonprescription medication you may use. Do not start or stop any medicine without doctor or pharmacist approval.
Mechanism of Action: Mosapride is a selective 5-HT4 receptor agonist. Mosapride stimulates 5-HT4 receptors in the gastrointestinal nerve plexus, which increases the release of acetylcholine, resulting in enhancement of gastrointestinal motility and gastric emptying.
Pregnancy Impact: Animal reproduction studies have failed to demonstrate a risk to the fetus and there are no adequate and well-controlled studies in pregnant women.
Impact During Lactation: There are no controlled studies in breastfeeding women, however the risk of untoward effects to a breastfed infant is possible; or, controlled studies show only minimal non-threatening adverse effects. Drugs should be given only if the potential benefit justifies the potential risk to the infant.
Price of Mosafe 2.5Mg : Rs.17.00
|Dispatches by||Next Day|
|Composition||Mosapride 2.5 mg|
|Pack Size||10 Tablet|
Use spaces to separate tags. Use single quotes (') for phrases.
FAQ on Mosafe 2.5Mg
There are no product questions yet.
We guarantee to ship your order next day after order has been submitted
Please contacts us and our customer service team will answer all your questions
If you are not satisfied with your order - send it back within 14 days after day of purchase!
Substitutes of Mosafe 2.5Mg
Rs.1.00Cyper Drugs & Pharma
Rs.1.00Orchid Chemicals & Pharma
Rs.1.00Low Cost Standard Therapeutics (Locost)
- Mail Today
- Bio Spectrum
- The Financial Chronicle
- Business Standard
- News Informer
- Business Standard
- News Prelease
- Biznews Index
- 15 Minute News
- Biz Radar
- VNI India
- Khari News
- Hunt News
- Express Pharma
- Silicon India
- The Hindu
- Your Story
- Stratos Invest
- EPL India
- Hindustan Times
- The Times of India